Highlights
NASDAQ: NBRV       Nabriva Therape Ads
Last Price Today's Change   Day's Range   Trading Volume
1.79   -0.08 (4.28%)  1.77 - 1.89  1,464,500

Overview

 
Avg Volume (4 weeks):855,294
4 Weeks Range:1.77 - 2.23
4 Weeks Price Volatility (%):
4.35%
52 Weeks Range:1.12 - 3.27
52 Weeks Price Volatility (%):
31.16%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Nabriva Therapeutics AG is a clinical stage biopharmaceutical company. Nabriva is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company is developing product candidate, lefamulin, to be the first pleuromutilin antibiotic available for systemic administration in humans. It operates in one reportable segment, which comprises the research and development of novel anti-infective agents to treat serious infections.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers